Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
1745studies shown
Showing 1,525-1,536 of 1,745
Drug study icon
TerminatedNCT04708834

Long-term Safety Study of Adjunctive Troriluzole in Subjects With OCD

This study exists to better understand the safety of the medication Adjunctive and how manageable it feels in practice. For people living with OCD, that matters because care needs to work in daily life, not just in theory.

In United Kingdom
OCDDrugFrom 18 Years to 65 Years
Countries
United States, Canada, United Kingdom, ...
Sponsor
Biohaven Pharmaceuticals, Inc.
Condition
OCD
Drug study icon
CompletedNCT00190684

Long-Term, Open Label Atomoxetine Study

This summary needs review. Please check the official study record and contact the research team for details.

In United Kingdom
ADHDDrugFrom 6 Years to 18 Years
Countries
United States, Australia, France, ...
Sponsor
Eli Lilly and Company
Condition
ADHD
Drug study icon
CompletedNCT05828940

Losartan and Memory

This summary needs review. Please check the official study record and contact the research team for details.

In United Kingdom
PTSDDrugFrom 18 Years to 50 Years
Countries
United Kingdom
Sponsor
University of Oxford
Condition
PTSD
Drug study icon
CompletedNCT01081145

Maintenance of Efficacy of Extended-Release Guanfacine HCl in Children and Adolescents With Attention-deficit/Hyperactivity Disorder (ADHD)

This study exists to understand how this type of care holds up over time after the earliest research stage. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.

In United Kingdom
ADHDDrugFrom 6 Years to 17 Years
Countries
United States, France, Canada, ...
Sponsor
Shire
Condition
ADHD
Behavioral study icon
CompletedNCT05518435

Managing Young People With ADHD in Primary Care Study

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

Remote / online
ADHDBehavioralOver 16 Years
Countries
United Kingdom
Sponsor
University of Exeter
Condition
ADHD
Behavioral study icon
CompletedNCT01981018

MAPP: Imagery-focused Therapy for Bipolarity

This study exists to see whether cognitive behavioural therapy, a structured talking treatment, can play a useful role in care. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning.

In United Kingdom
BipolarityBehavioralFrom 18 Years to 65 Years
Countries
United Kingdom
Sponsor
Medical Research Council Cognition and Brain Sciences Unit
Condition
Bipolarity
Other study type icon
TerminatedISRCTN11696836

Maternal moments

This public ISRCTN record appears to relate to anxiety. HopeStage keeps this listing available so people can review the official source, understand the basic study status, and decide what questions to ask before contacting the research team.

In United Kingdom
Anxiety, DepressionOtherFrom 18 Years to 45 Years
Countries
United Kingdom
Sponsor
Goldsmiths, University of London
Condition
Anxiety, Depression
Drug study icon
Active Not RecruitingNCT07164755

Measurement of Serum Inflammatory Markers in Patients Treatment-resistant Depression Given Psilocybin

This observational study is following people with Depression - depression to understand outcomes over time. Participants are followed through routine care so researchers can learn from the treatment and outcomes already taking place.

In United Kingdom
DepressionOtherFrom 25 Years to 80 Years
Countries
United Kingdom
Sponsor
King's College London
Condition
Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.